Clinical Trials Sponsored by National Cancer Institute, Milan

Total 22239 results

National Cancer Institute (NCI)

Withdrawn

Gut Microbiota in People With Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma | Liver Neoplasm | Liver Cancer | Liver Cell Caricinoma
National Cancer Institute (NCI)

Withdrawn

Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas

Primary Effusion Lymphoma | Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease
National Cancer Institute (NCI)

Completed

TKM 080301 for Primary or Secondary Liver Cancer

Colorectal Cancer With Hepatic Metastases | Pancreas Cancer With Hepatic Metastase | Gastric Cancer With Hepatic Metastase | Breast Cancer With Hepatic Metastase | Ovarian Cancer With Hepatic Metastase

United States
National Cancer Institute (NCI)

Completed

Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma

Sarcoma, Kaposi

United States
National Cancer Institute (NCI)

Withdrawn

18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma

Carcinoma, Non-Small-Cell Lung | Thymus Neoplasms
National Cancer Institute (NCI)

Completed

Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants

Multiple Myeloma | Chronic Lymphocytic Leukemia | Graft vs Host Disease | Non Hodgkin's Lymphoma | Hodgkin's Disease

United States
National Cancer Institute (NCI)

Completed

Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma

Sarcoma | Neuroectodermal Tumors, Primitive, Peripheral | Neuroblastoma | Rhabdomyosarcoma-Embryonal | Rhabdomyosarcoma- Alveolar

United States
National Cancer Institute (NCI)

Completed

A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment

Cancer | Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy

Peritoneal Mesothelioma | Pleural Mesothelioma

United States
National Cancer Institute (NCI)

Completed

Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191

Cervical Neoplasia | HPV Infections

Costa Rica
National Cancer Institute (NCI)

Completed

Testing the FLASHE Survey

Survey | Interview | Cognitive Testing

United States
National Cancer Institute (NCI)

Completed

HPV Vaccine Effectiveness in Partially Vaccinated Girls in Uganda

HPV16 Anitbody Levels Post Vaccination | HPV18 Antibody Levels Post Vaccination

Uganda
National Cancer Institute (NCI)

Completed

Feasibility Study for Prospective Diet and Lifestyle Cohorts in Delhi, Kerala, and Kolkota, India

Chronic Diseases

India
National Cancer Institute (NCI)

Completed

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

Cervical Cancer | Anal Cancer | Vaginal Cancer | Oropharyngeal Cancer | Penile Cancer

United States
National Cancer Institute (NCI)

Completed

Anti-Tac(Fv)-PE38 (LMB-2) to Treat Cutaneous T-Cell Lymphomas

Lymphoma | Cutaneous | T-Cell

United States
National Cancer Institute (NCI)

Completed

TRC105 for Liver Cancer That Has Not Responded to Sorafenib

Carcinoma, Hepatocellular | Hepatocellular Carcinoma | Hepatocellular Cancer

United States
National Cancer Institute (NCI)

Withdrawn

In Vivo Persistence of Adoptively-Transferred TIL Cultured With Akti in People With Metastatic Melanoma

Metastatic Melanoma
National Cancer Institute (NCI)

Completed

Genetic and Protein Profiling in Normal and Cancerous Breast Tissue

Breast Neoplasms

United States
National Cancer Institute (NCI)

Completed

Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines

Lymphoma | Follicular Lymphoma | B Cell Lymphoma

United States
National Cancer Institute (NCI)

Completed

Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer

Breast Cancer

United States
National Cancer Institute (NCI)

Completed

Pilot Study of Inflammatory Breast Cancer in Egypt and Tunisia

Inflammatory Breast Cancer

Egypt, Tunisia
National Cancer Institute (NCI)

Completed

Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers

HIV Infections | Acquired Immunodeficiency Syndrome | Lymphoma | Leukemia | Kaposi's Sarcoma | Tumor Virus Infection

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Completed

Evaluation of Blood Vessel Formation in Endocrine Tumors

Lesions

United States
National Cancer Institute (NCI)

Completed

Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial

Lymphoma | Hodgkin's Disease

United States
National Cancer Institute (NCI)

Completed

A Comparison Study of Two Community Outreach-Based Approaches to Increase Participation of Women Living in the Mississippi Delta in Cervical Cancer Screening

Cervical Intraepithelial Neoplasia | Human Papillomavirus

United States
National Cancer Institute (NCI)

Completed

Collection of Alveolar Soft Part Sarcoma and Blood Specimens for Research

Sarcoma | Alveolar Soft Part Sarcoma

United States
National Cancer Institute (NCI)

Withdrawn

ABT-888, Carboplatin, and Paclitaxel for Cancer With Liver or Kidney Problems

Neoplasms

United States
National Cancer Institute (NCI)

Completed

Pharmacokinetic Studies Participation Survey

Relapsed Solid Tumors | Relapsed Leukemia | Relapsed Brain Tumors

United States
National Cancer Institute (NCI)

Completed

HLA and KIR Associations With Infectious Viral Agents in an HIV Cohort of Women (WIHS)

HIV

United States
National Cancer Institute (NCI)

Completed

In Vitro Study of Peripheral Blood Mononuclear Cell Function in Healthy Individuals and Patients

Cell Function

United States
National Cancer Institute (NCI)

Completed

A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy

Prostatic Neoplasms

United States
National Cancer Institute (NCI)

Completed

Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer

Breast Cancer

United States
National Cancer Institute (NCI)

Withdrawn

A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors

Glioma | Pinealoma | Brain Stem Neoplasms
National Cancer Institute (NCI)

Completed

Calibration of Urine pH Strips for NCI Case-Control Studies on Bladder Cancer and Comparison of DNA Yields From Buccal Cells Collected Through Two Different Methods

Calibration

United States
National Cancer Institute (NCI)

Completed

Pilots of Self-Collection for HPV DNA Detection

HPV

United States
National Cancer Institute (NCI)

Completed

Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype

Follicular Lymphoma | B Cell Lymphoma | Neoplasm

United States
National Cancer Institute (NCI)

Completed

Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein

Neoplasms

United States
National Cancer Institute (NCI)

Completed

Low-Cost Molecular Cervical Cancer Screening Study

Uterine Cervical Neoplasms | HPV | DNA Probes | E6 Protein

United States, China
National Cancer Institute (NCI)

Completed

Collection of Blood, Bone Marrow, Tumor or Tissue Samples

Neoplasms | Precancerous Conditions

United States
National Cancer Institute (NCI)

Completed

Exercise in Women at Risk for Breast Cancer

Breast Neoplasms

United States
National Cancer Institute (NCI)

Completed

Evaluating Serum Sex Steroid Hormones

Validation

United States
National Cancer Institute (NCI)

Completed

Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers

Hepatitis C Virus

United States
National Cancer Institute (NCI)

Completed

Family Health Study (Validation of a Family History of Cancer Questionnaire for Risk Factor Surveillance)

Cancer

United States
National Cancer Institute (NCI)

Completed

Relationship of pAKT to Survival in Patients With Node-Positive Breast Cancer

Breast Cancer

United States
National Cancer Institute (NCI)

Completed

International Cooperation for Post-Cherynobyl NIS Thyroid Tissue and Data Banks

Environment

United States
National Cancer Institute (NCI)

Completed

Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1

Human T-Lymphoma Virus Type I

United States, Jamaica, Japan
National Cancer Institute (NCI)

Completed

Gene Therapy for Patients With Leukocyte Adherence Deficiency (Follow-Up of Phase 1 Trial)

Leukocyte Adhesion Deficiency Syndrome

United States
National Cancer Institute (NCI)

Completed

A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis

HTLV-I

Jamaica

Clinical Trials Sponsored by National Cancer Institute, Milan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations